Peptide Therapeutics Market Detailed Analysis On Forthcoming Development And Forecast By 2028
Peptides represent a unique class of pharmaceutical compounds, it is recognized for being efficacious and selective. Demand for peptides in clinical therapeutics is expected to increase as peptides have low production complexity as compared to that of protein based biopharmaceuticals, which thereby reduces overall production cost.
The global peptide therapeutics market revenue is expected to register a moderate CAGR over the forecast period. Increasing number of cases of cardiovascular diseases & cancer, continuous focus of manufacturers to develop novel and innovative products are major factors expected to drive growth the global peptide therapeutics market over the forecast period.
The global peptide therapeutics market report has been segmented on the basis of type, technology, application, route of administration, and region.
Based on technology, the target market is segmented based on solid phase peptide synthesis (SPPS), liquid phase peptide synthesis (LPPS), and hybrid technology. The liquid phase peptide synthesis (LPPS) accounts for major revenue share.
Based on route of administration, the global target market is segmented based on oral administration, parenteral administration, and others.
Based on application, the global peptide therapeutics market is segmented based on cancer, metabolic disease, respiratory disease, cardiovascular disease, infectious disease, and others. The peptide therapeutics in cancer application accounts for major revenue share, owing to increasing incidence of cancer and need to develop and treat the disease will in turn is expected to drive growth of the segment over the forecast period.
Get Free Sample Copy Of This Research @ https://marketresearch.biz/report/peptide-therapeutics-market/request-sample/
Regional segmentation includes North America, Europe, Latin America, Asia Pacific and Middle East and Africa. North America contributes major market share and expected to maintain its dominance over the forecast period. Asia Pacific region is expected to witness rapid growth rate over the forecast period. Countries like India and China is expected to support the growth of Asia Pacific market, owing to increasing incidences of cardiovascular and respiratory diseases in the region over the forecast period.
Some prominent players in the global peptide therapeutics market are Bachem Holding AG, Eli Lilly and Company, Pfizer Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Lonza Inc., Sanofi S.A., Bristol-Myers Squibb(BMS), and AstraZeneca PLC.